Ginwa Enterprise (Group) Inc. (SHA:600080)

China flag China · Delayed Price · Currency is CNY
8.71
-0.08 (-0.91%)
Mar 11, 2026, 3:00 PM CST
12.10%
Market Cap 3.10B
Revenue (ttm) 550.44M
Net Income (ttm) 78.32M
Shares Out 352.71M
EPS (ttm) 0.23
PE Ratio 38.95
Forward PE n/a
Dividend 0.03 (0.34%)
Ex-Dividend Date n/a
Volume 8,398,873
Average Volume 13,977,115
Open 8.77
Previous Close 8.79
Day's Range 8.68 - 8.89
52-Week Range 6.23 - 9.35
Beta 0.39
RSI 58.30
Earnings Date Apr 25, 2026

About Ginwa Enterprise (Group)

Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China. [Read more]

Sector Healthcare
Founded 1996
Employees 588
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.